Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1179-1192

  Mitchell, Nick ^a   Kalber, Tammy L ^a   Cooper, Margaret S ^b   Sunassee, Kavitha ^b   Chalker, Samantha L ^a,c   Shaw, Karen P ^a   Ordidge, Katherine L ^a   Badar, Adam ^a   Janes, Samuel M ^a   Blower, Philip J ^b,d   Lythgoe, Mark F ^a   Hailes, Helen C ^a   Tabor, Alethea B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c DAVY FARADAY RESEARCH LABORATORY   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

DCC; DEG1SL; DEG3SL; DEG6SL; DODEG4; DOPE; DOTA; DOTA lipid; DOTMA; DSPE PEG2000; DTPA; EPR; FL DHPE; HBTU; ITLC; Liposome; MR; MRI (magnetic resonance imaging); N EG; PEG; PEG (poly(ethylene)glycol); PET; RES; SPECT; SPECT (single photon emission tomography)

Indexed keywords

DCC; DEG1SL; DEG3SL; DEG6SL; DODEG4; DOPE; DOTA; DOTA-LIPID; DOTMA; DSPE-PEG2000; DTPA; FL-DHPE; HBTU; ITLC; MR; MRI (MAGNETIC RESONANCE IMAGING); N-EG; RES; SINGLE-PHOTON EMISSION TOMOGRAPHY; SPECT;

CHELATION; ETHYLENE; ETHYLENE GLYCOL; GADOLINIUM; LIPIDS; MAGNETIC RESONANCE IMAGING; PARAMAGNETIC RESONANCE; PARAMAGNETISM; PARTICLE BEAMS; POLYETHYLENE GLYCOLS; POLYETHYLENE TEREPHTHALATES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TOMOGRAPHY;

LIPOSOMES;

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [CARBOXY(POLYETHYLENEGLYCOL)2000]; CONTRAST MEDIUM; COPPER 64; GADOLINIUM CHELATE; GADOTERATE MEGLUMINE; INDIUM 111; LIPID; LIPOSOME; MACROGOL; MACROGOL 2000; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; TETRAXETAN; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHELATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLUORESCENCE; HALF LIFE TIME; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; MOLECULARLY TARGETED THERAPY; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; TUMOR CELL;

CONTRAST MEDIA; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICROSCOPY, FLUORESCENCE; NANOCAPSULES; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84870381622     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.070     Document Type: Article

References (56)

1. Malam Y., Loizidou M., Seifalian A.M. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 2009, 30:592-599.
2. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990, 268:235-237.
3. Stathopoulos G.P., Boulikas T., Vougiouka M., Deliconstantinos G., Rigatos S., Darli E., et al. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin™): phase I study. Oncol Rep 2005, 13:589-595.
4. Ning Y.M., He K., Dagher R., Sridhara R., Farrell A.T., Justice R., et al. Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma. Oncology 2007, 21:1503-1508.
5. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3:401-410.
6. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011, 63:161-169.
7. Hatakeyama H., Akita H., Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 2011, 63:152-160.
8. Song L.Y., Ahktong Q.F., Rong Q., Wang Z., Ansell S., Hope M.J., et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002, 1558:1-13.
9. Rudolph C., Schillinger U., Plank C., Gessner A., Nicklaus P., Müller R.H., et al. Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim Biophys Acta 2002, 1573:75-83.
10. Hurley C.A., Wong J.B., Ho J., Writer M., Hart S.L., Lawrence M.J., et al. Di- and Monocationic short PEG and methylene dioxyalkylglycerols for use in synthetic gene delivery systems. Org Biomol Chem 2008, 6:2554-2559.
11. Mohd Mustapa M.F., Grosse S.M., Kudsiova L., Elbs M., Raiber E.-A., Wong J.B., et al. Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell. Bioconj Chem 2009, 20:518-532.
12. Grosse S.M., Tagalakis A.D., Mohd Mustapa M.F., Elbs M., Meng Q.-H., Mohammadi A., et al. Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers. FASEB J 2010, 24:2301-2313.
13. Strijkers G.J., Kluza E., Van Tilborg G.A.F., van der Schaft D.W.J., Griffioen A.W., Mulder W.J.M., et al. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 2010, 13:161-173.
14. Oliver M., Ahmad A., Kamaly N., Perouzel E., Caussin A., Keller M., et al. MAGfect: a novel liposome formulation for MRI labelling and visualization of cells. Org Biomol Chem 2006, 4:3489-3497.
15. Erten A., Wrasidlo W., Scadeng M., Esener S., Hoffman R.M., Bouvet M., et al. Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model. Nanomedicine 2010, 6:797-807.
16. Kamaly N., Kalber T., Ahmad A., Oliver M.H., So P.-W., Herlihy A.H., et al. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconj Chem 2008, 19:118-129.
17. Kenny G.D., Kamaly N., Kalber T.L., Brody L.P., Sahuri M., Shamsaei E., et al. Novel multifunctional nanoparticle mediates siRNA tumor delivery, visualization and therapeutic tumour reduction in vivo. J Contr Release 2011, 149:111-116.
18. Leclercq F., Cohen-Ohana M., Mignet N., Sbarbati A., Herscovici J., Scherman D., et al. Design, synthesis and evaluation of gadolinium cationic lipids as tools for biodistribution studies of gene delivery complexes. Bioconj Chem 2003, 14:112-119.
19. Mulder W.J., Strijkers G.J., van Tilborg G.A., Griffioen A.W., Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006, 19:142-164.
20. Erdogan S., Medarova Z.O., Roby A., Moore A., Torchilin V.P. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor targeted liposomes. J Magn Reson Imag 2008, 2008(27):574-580.
21. de Vries A., Kok M.B., Sanders H.M.H.F., Nicolay K., Strijkers G.J., Grull H. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements. Contrast Media Mol Imag 2012, 7:68-75.
22. Silindir M., Ozer A.Y., Erodgan S. The use and importance of liposomes in Positron Emission Tomography. Drug Deliv 2012, 19:68-80.
23. Boerman O.C., Storm G., Oyen W.J.G., van Bloois L., van der Meer J.W.M., Clessens R.A.M.J., et al. Sterically stabilized liposomes labelled with Indium-111 to image focal infection. J Nucl Med 1995, 36:1639-1644.
24. Kobayashi H., Sato N., Kawamoto S., Saga T., Hiraga A., Haque T.L., et al. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer. Bioconj Chem 2001, 12:100-107.
25. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002, 2:1-8.
26. Lee D.-E., Koo H., Sun I.-C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
27. Kamaly N., Miller A.D. Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int J Mol Sci 2010, 11:1759-1776.
28. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006, 35:512-523.
29. Overoye-Chan K., Koerner S., Looby R.J., Kolodziej A.F., Zech S.G., Deng Q., et al. EP-2104R: a fibrin-specific gadolinium-based MRI contrast agent for detection of thrombus. J Am Chem Soc 2008, 130:6025-6039.
30. Phillips W.T., Goins B.A., Bao A. Radioactive liposomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:69-83.
31. 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials 2011, 32:2334-2341.
32. 111In-labelled nanoparticles. J Pharm Sci 2012, 101:2271-2280.
33. 64Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity and in vitro/in vivo stability. Bioconj Chem 2012, 23:1029-1039.
34. Huang L.R., Quada J.C., Lown J.W. Design, synthesis, and sequence-selective DNA cleavage of functional models of Bleomycin. 1. Hybrids incorporating a simple metal-complexing moiety of Bleomycin and Lexitropsin carriers. Bioconj Chem 1995, 6:21-33.
35. Trester-Zedlitz M., Kamada K., Burley S.K., Fenyö D., Chait B.T., Muir T.W. A modular cross-linking approach for exploring protein interactions. J Am Chem Soc 2003, 125:2416-2425.
36. Krishnamurthy V.M., Semetey V., Bracher P.J., Shen N., Whitesides G.M. Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J Am Chem Soc 2007, 129:1312-1320.
37. LaFrate A.L., Carlson K.E., Katzenellenbogen J.A. Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities. Bioorg Med Chem 2009, 17:3528-3535.
38. G-Acyl-argininamides as NPY Y1 receptor antagonists: influence of structurally diverse acyl substituents on stability and affinity. Bioorg Med Chem 2010, 18:6292-6304.
39. Hurley C.A., Wong J.B., Hailes H.C., Tabor A.B. Asymmetric synthesis of dialkyloxy-3-alkylammonium cationic lipids. J Org Chem 2004, 69:980-983.
40. Wängler C., Wängler B., Eisenhut M., Haberkorn U., Mier W. Improved syntheses and applicability of different DOTA building blocks for multiply derivatized scaffolds. Bioorg Med Chem 2008, 16:2606-2616.
41. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection - a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84:7413-7417.
42. Larsson A., Angbrant J., Ekeroth J., Månsson P., Leidberg B. A novel biochip technology for detection of explosives - TNT: synthesis, characterisation and application. Sensor Actuator B Chem 2006, 113:730-748.
43. Collet M., Lenger J., Jenssen K., Plattner H.P., Sewald N. Molecular tools for metalloprotease sub-proteome generation. J Biotechnol 2007, 129:316-328.
44. Barge A., Cravotto G., Gianolio E., Fedeli F. How to determine free Gd and free ligand in solution of Gd chelates. A technical note. Contrast Media Mol Imag 2006, 1:184-188.
45. Seo J.W., Qin S., Mahakian L.M., Watson K.D., Kheirolomoom A., Ferrara K.W. Positron emission tomography imaging of the stability of Cu-64 labelled dipalmitoyl and distearoyl lipids in liposomes. J Contr Release 2011, 151:28-34.
46. Rasband W.S. ImageJ 2008, U.S. National Institutes of Health, Bethesda, MD. http://rsb.info.nih.gov/ij/.
47. Miller A.D. Cationic liposomes for gene therapy. Angew Chem Int Ed 1998, 37:1768-1785.
48. Maruyama K., Yuda T., Okamoto A., Kojima S., Suginaka A., Iwatsuru M. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992, 1128:44-49.
49. Bertini I., Bianchini F., Calorini L., Colagrande S., Fragai M., Franch A., et al. Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. Magn Reson Med 2004, 52:669-672.
50. 1H-NMRD study of biotinylated paramagnetic liposomes containing Gd-bis-SDA-DTPA or Gd-DMPE-DTPA. Inorganica Chim Acta 2002, 331:151-157.
51. Strijkers G.J., Mulder W.J.M., van Heeswijk R.B., Frederik P.M., Bomans P., Magusin P.C., et al. Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA 2005, 18:186-192.
52. Kielar F., Tei L., Terreno E., Botta M. Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd-III chelates. J Am Chem Soc 2010, 132:7836-7837.
53. Storrs R.W., Tropper F.D., Li H.Y., Song C.K., Kuniyoshi J.K., Simkins D.A., et al. Paramagnetic polymerized liposomes: synthesis, characterisation, and applications for magnetic resonance imaging. J Am Chem Soc 1995, 117:7301-7306.
54. Laurent S., Elst L.V., Thirifays C., Muller R.N. Relaxivities of paramagnetic liposomes: on the importance of the chain type and the length of the amphiphilic complex. Eur Biophys J 2008, 37:1007-1014.
55. Caravan P., Farrara C.T., Frullanoa L., Uppal R. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imag 2009, 4:89-100.
56. Kamaly N., Pugh J.A., Kalber T.L., Bunch J., Miller A.D., McLeod C.W., et al. Imaging of gadolinium spatial distribution in tumour tissue by laser ablation inductively coupled plasma mass spectrometry. Mol Imag Biol 2010, 12:361-366.